Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
Open accessAbstract
Chromosomal deletions associated with human diseases, such as cancer, are common, but synteny issues complicate modeling of these deletions in mice. We use cellular reprogramming and genome engineering to functionally dissect the loss of chromosome 7q (del(7q)), a somatic cytogenetic abnormality present in myelodysplastic syndromes (MDS). We derive del(7q)- and isogenic karyotypically normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS patients and show that the del(7q) iPSCs recapitulate disease-associated phenotypes, including impaired hematopoietic differentiation. These disease phenotypes are rescued by spontaneous dosage correction and can be reproduced in karyotypically normal cells by engineering hemizygosity of defined chr7q segments in a 20-Mb region. We use a phenotype-rescue screen to identify candidate haploinsufficient genes that might mediate the del(7q)- hematopoietic defect. Our approach highlights the utility of human iPSCs both for functional mapping of disease-associated large-scale chromosomal deletions and for discovery of haploinsufficient genes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The normal iPSC line N-2.12-D-1-1 served as the parental line for all CRISPR/Cas9-edited lines used in this study.
“The previously described normal induced pluripotent stem cell (iPSC) line N-2.12-D-1-1 served as the parental line of all CRISPR/Cas9-edited lines used in this study106.”
From Somatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative states (2026) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Genome structural variation discovery and genotyping
Alkan, C., Coe, B. P., & Eichler, E. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2958 · Cited by 1,630 · see citing works
Evolution and functional impact of rare coding variation from deep sequencing of human exomes
Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613 · see citing works
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575 · see citing works
Self-citationRare and common variants: twenty arguments
Gibson, G. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3118 · Cited by 1,278 · see citing works
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139 · see citing works
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., Schrier, S. L., & Weissman, I. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116110108 · Cited by 991 · see citing works
Gene Copy-Number Alterations: A Cost-Benefit Analysis
Tang, Y.-C., & Amon, A. (2013) · Cell · doi:10.1016/j.cell.2012.11.043 · Cited by 348 · see citing works
Papapetrou, E. P., Tomishima, M. J., Chambers, S. M., Mica, Y., Reed, E., Menon, J., Tabar, V., Mo, Q., Studer, L., & Sadelain, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904825106 · Cited by 286 · see citing works
Self-citationNovel homo- and hemizygous mutations in EZH2 in myeloid malignancies
Makishima, H., Jankowska, A. M., Tiu, R. V., Szpurka, H., Sugimoto, Y., Hu, Z., Saunthararajah, Y., Guinta, K., Keddache, M. A., Putnam, P., et al. (2010) · Leukemia · doi:10.1038/leu.2010.167 · Cited by 179 · see citing works
Molecular Pathophysiology of Myelodysplastic Syndromes
Lindsley, R. C., & Ebert, B. L. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132436 · Cited by 88 · see citing works
Flagged first, then by citations
Research works printed but not linked: 40
- [1]Beroukhim R The landscape of somatic copy-number alteration across human cancers Nature 463 899 905 2010 20164920 PMC2826709
- [3]Weischenfeldt J Symmons O Spitz F Korbel JO Phenotypic impact of genomic structural variation: insights from and for human disease Nat Rev Genet 14 125 138 2013 23329113
- [5]Li J PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1943 1947 1997 9072974
- [6]Berger AH Knudson AG Pandolfi PP A continuum model for tumour suppression Nature 476 163 169 2011 21833082 PMC3206311
- [7]Solimini NL Recurrent hemizygous deletions in cancers may optimize proliferative potential Science 337 104 109 2012 22628553 PMC4027969
- [9]Jerez A Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis Blood 119 6109 6117 2012 22553315 PMC3383019
- [10]Soldner F Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations Cell 146 318 331 2011 21757228 PMC3155290
- [11]Grskovic M Javaherian A Strulovici B Daley GQ Induced pluripotent stem cells--opportunities for disease modelling and drug discovery Nat Rev Drug Discov 10 915 929 2011 22076509
- [12]Papapetrou EP Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells Nat Biotechnol 29 73 78 2011 21151124 PMC3356916
- [13]Papapetrou EP Sadelain M Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector Nat Protoc 6 1251 1273 2011 21886095
- [14]Walter MJ Clonal architecture of secondary acute myeloid leukemia N Engl J Med 366 1090 1098 2012 22417201 PMC3320218
- [15]Sturgeon CM Ditadi A Clarke RL Keller G Defining the path to hematopoietic stem cells Nat Biotechnol 31 416 418 2013 23657396
- [16]Kennedy M T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures Cell Rep 2 1722 1735 2012 23219550
- [17]Flores-Figueroa E Gutierrez-Espindola G Guerrero-Rivera S Pizzuto-Chavez J Mayani H Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation Leuk Res 23 385 394 1999 10229325
- [18]Sato T Kim S Selleri C Young NS Maciejewski JP Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome Leukemia 12 1187 1194 1998 9697872
- [19]Amps K Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage Nat Biotechnol 29 1132 1144 2011 22119741 PMC3454460
- [20]Narva E High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity Nat Biotechnol 28 371 377 2010 20351689
- [21]Li LB Trisomy correction in down syndrome induced pluripotent stem cells Cell Stem Cell 11 615 619 2012 23084023 PMC3705773
- [22]Lewandoski M Martin GR Cre-mediated chromosome loss in mice Nat Genet 17 223 225 1997 9326948
- [23]Matsumura H Targeted chromosome elimination from ES-somatic hybrid cells Nat Methods 4 23 25 2007 17086180
- [24]Davoli T Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome Cell 155 948 962 2013 24183448 PMC3891052
- [25]Xue W A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions Proc Natl Acad Sci U S A 109 8212 8217 2012 22566646 PMC3361457
- [26]Ebert BL Identification of RPS14 as a 5q- syndrome gene by RNA interference screen Nature 451 335 339 2008 18202658 PMC3771855
- [27]Starczynowski DT Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype Nat Med 16 49 58 2010 19898489
- [29]Nikoloski G Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes Nat Genet 42 665 667 2010 20601954
- [30]Lindsley RC Ebert BL The biology and clinical impact of genetic lesions in myeloid malignancies Blood 2013 23954890
- [33]Shih AH Abdel-Wahab O Patel JP Levine RL The role of mutations in epigenetic regulators in myeloid malignancies Nat Rev Cancer 12 599 612 2012 22898539
- [34]Gonzalez F An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells Cell Stem Cell 15 215 226 2014 24931489 PMC4127112
- [35]Young MA Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells Cell Stem Cell 10 570 582 2012 22542160 PMC3348423
- [36]Abyzov A Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells Nature 492 438 442 2012 23160490 PMC3532053
- [38]Le Beau MM Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases Blood 88 1930 1935 1996 8822909
- [39]Dohner K Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders Blood 92 4031 4035 1998 9834205
- [40]Chen C MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia Cancer Cell 25 652 665 2014 24794707 PMC4206212
- [42]Carette JE Haploid genetic screens in human cells identify host factors used by pathogens Science 326 1231 1235 2009 19965467
- [43]White JK Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes Cell 154 452 464 2013 23870131 PMC3717207
- [44]Bolze A Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia Science 340 976 978 2013 23579497 PMC3677541
- [45]Hosono N Recurrent genetic defects on chromosome 7q in myeloid neoplasms Leukemia 28 1348 1351 2014 24429498 PMC8694066
- [46]Singh H Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies Blood cancer journal 3 e117 2013 23708642 PMC3674458
- [49]Cibulskis K Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples Nat Biotechnol 31 213 219 2013 23396013 PMC3833702
- [50]Papapetrou EP Korkola JE Sadelain M A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells Stem Cells 28 287 296 2010 19911427
Cited by
Sorted by citations
Induced Pluripotent Stem Cells Meet Genome Editing
Hockemeyer, D., & Jaenisch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.013 · Cited by 499 · see citing works
“This system has been used to generate loss of function alleles in EZH2 and to demonstrated the effects of haploinsufficeny for EZH2 in hematopoietic differentiation (Kotini et al., 2015).”
MethodPolycomb repressive complexes in hematological malignancies
Iwama, A. (2017) · Blood · doi:10.1182/blood-2017-02-739490 · Cited by 55 · see citing works
Matatall, K. A., Wathan, T. K., Nguyen, M., Chen, H., McDonald, A., Qi, G., Belk, J. A., Florez, M. A., Le, D. T., Olarinde, T., et al. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.06.006 · Cited by 23 · see citing works
Self-citationEffect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Charaf, L., Mahon, F.-X., Lamrissi-Garcia, I., Moranvillier, I., Beliveau, F., Cardinaud, B., Dabernat, S., de Verneuil, H., Moreau-Gaudry, F., & Bedel, A. (2017) · Leukemia · doi:10.1038/leu.2016.154 · Cited by 16 · see citing works
Huang, A. Y., Zhou, Z., Talukdar, M., Enyenihi, L., Miller, M. B., Chhouk, B., Rosen, I., Zheng, M., Zhou, M., Yang, A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.040 · Cited by 15 · see citing works
Self-citation
- Authors
- Kotini, A. G., Chang, C.-J., Boussaad, I., Delrow, J. J., Dolezal, E. K., Nagulapally, A. B., Perna, F., Fishbein, G. A., Klimek, V. M., Hawkins, R. D., Huangfu, D., Murry, C. E., Graubert, T., Nimer, S. D., & Papapetrou, E. P.
- Affiliations
- Tisch Cancer Institute (US)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- University of Miami (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of California, Los Angeles (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Papapetrou, Eirini P
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2015-03-23
- Volume
- 33
- Issue
- 6
- Pages
- 646-655
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4464949
- OpenAlex
- W2074191990
- Cited by
- 171
- References
- 10
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 13 · 2023: 8 · 2022: 11 · 2021: 21 · 2020: 14 · 2019: 13 · 2018: 18 · 2017: 25 · 2016: 21 · 2015: 10 · 2013: 1
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Sidney Kimmel Foundation for Cancer Research
- University of Washington
- Sidney Kimmel Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL121570)
- National Cancer Institute (P30CA 15704, P30CA008748, P30CA015704, R01CA166835)
- National Institute of Diabetes and Digestive and Kidney Diseases (R00DK087923, R01DK096239)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- chromosome 7q deletion, myelodysplastic syndrome, induced pluripotent stem cells, haploinsufficiency, hematopoietic differentiation, hemizygosity, chromosomal abnormalities
- MeSH terms
- Animals, Chromosome Deletion, Chromosomes, Human, Pair 7, Genetic Engineering, Humans, Karyotyping, Myelodysplastic Syndromes, Mice, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review